Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545843 · ClinicalTrials.gov registry record · Phase 2
Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
A Phase 2 study of Depression, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT01545843: Completed Phase 2 study of Depression, sponsored by University of Michigan.
NCT01545843 is a Phase 2 study of Depression that has completed, run by University of Michigan. The registered enrollment target is 68 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01545843, a Phase 2 study of Depression, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether changing sleep patterns improves response to an antidepressant medication.
Primary Outcome
Total score on a clinician-rated measure of depressive symptoms, minus 3 sleep items Total score range: 0-46. Higher scores represent more severe depression.
Conditions Studied
Interventions
- DRUG Fluoxetine
- BEHAVIORAL Sleep scheduling
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
What the finished NCT01545843 record still lists
NCT01545843 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Fluoxetine is the first listed.
NCT01545843 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01545843 about?
NCT01545843 is a clinical study titled "Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression". The purpose of the study is to determine whether changing sleep patterns improves response to an antidepressant medication.
What is the current status of trial NCT01545843?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2009-03. Estimated completion is 2012-12.
What conditions does trial NCT01545843 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT01545843?
The interventions under investigation include: Fluoxetine (DRUG), Sleep scheduling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01545843?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01545843 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01545843's enrollment target sits among peer trials
68 415th of 679 higher than 263 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia